Making US Generic Drug Production Financially Viable: Senate Hearing

Challenges in US Generic Drug Production

• 🇺🇸 Senator Tommy Tuberville questioned Allan Coukell of CivicaRx on making US generic drug production financially viable.
• 📉 Current production is limited to 100 million doses a month due to distributors prioritizing cost over other factors.
• 🏭 To quadruple production from 180 million to over 600 million doses per month, an additional $18 million in capital expenditure for equipment is needed.

Procurement and Policy Reforms

• 🛒 The VA and DoD procurement process is described as slow, with opportunities to sell to these channels needing significant growth.
• ⚖️ A recent bid was lost to a Chinese-American firm partnered with Indian-Americans, highlighting a need for a clearer, level playing field in procurement policies.
• 💲 To make US generic drug production financially viable, purchasers need to select for quality and domestic manufacturers, even if it costs slightly more.

FDA Inspections and Compliance

• 🧐 FDA inspections are unannounced, and discovering a violation could lead to a 483 notice.
• ⚖️ A 483 notice signifies a violation against the law, potentially leading to the facility being closed and executives being indicted.